Background: Malnutrition or its risk is common among patients with cancer (from 15% to 90%) and can negatively impact treatment outcomes and quality of life. Early detection and nutritional intervention are essential to improve clinical, health, and economic outcomes. This study evaluates the PRONTO (PROtocol for NuTritional risk in Oncology), a novel tool designed for the early identification of nutritional risk in patients with cancer.Objectives: To assess the feasibility of the PRONTO in detecting nutritional risk among newly diagnosed oncology patients.Methods: This cross-sectional, observational pilot study included 200 patients from two oncology centers in Madrid, Spain. The PRONTO was applied during the first oncology visit. Nutritional risk was assessed using PRONTO and nutritional status was evaluated with the Global Leadership Initiative on Malnutrition (GLIM) criteria. Tool acceptability was measured using the System Usability Scale (SUS) and Net Promoter Score (NPS) among participating oncologists.Results: The PRONTO identified 62.0% of patients at nutritional risk, while malnutrition was confirmed in 57.0% of patients using GLIM criteria. The PRONTO demonstrated high sensitivity (90.4%) and specificity (75.6%) compared to the GLIM. Oncologists rated the PRONTO highly, with a SUS score of 87.9 and an NPS of 9.1, indicating strong usability and recommendation potential.Conclusions: The PRONTO is a feasible and practical tool for early nutritional risk screening in oncology settings. Its simplicity and efficiency support its integration into routine clinical practice. The high prevalence of nutritional risk underscores the need for early screening to guide timely nutrition care. Further research with larger and diverse groups of patients and oncologists is needed to validate scalability and assess the impact of nutritional interventions on patient outcomes.
背景：营养不良或其风险在癌症患者中较为常见（发生率15%至90%），可能对治疗效果和生活质量产生负面影响。早期发现与营养干预对于改善临床、健康及经济结局至关重要。本研究评估了新型肿瘤营养风险筛查工具PRONTO（肿瘤营养风险筛查方案），该工具专为早期识别癌症患者营养风险而设计。 目的：评估PRONTO在新诊断肿瘤患者中筛查营养风险的可行性。 方法：这项横断面观察性预试验纳入了西班牙马德里两家肿瘤中心的200例患者。在首次肿瘤科就诊时应用PRONTO进行筛查。营养风险通过PRONTO进行评估，营养状况则采用全球营养不良领导倡议标准进行判定。通过系统可用性量表和净推荐值评估参与研究的肿瘤科医生对该工具的接受度。 结果：PRONTO筛查出62.0%的患者存在营养风险，而采用全球营养不良领导倡议标准确认57.0%的患者存在营养不良。与全球营养不良领导倡议标准相比，PRONTO显示出较高的敏感性（90.4%）和特异性（75.6%）。肿瘤科医生对PRONTO评价良好，系统可用性量表得分87.9分，净推荐值9.1分，表明该工具具有良好的可用性和推荐价值。 结论：PRONTO是肿瘤临床实践中可行且实用的早期营养风险筛查工具。其简便高效的特点支持其融入常规临床工作。营养风险的高发生率凸显了早期筛查对指导及时营养干预的必要性。未来需要纳入更广泛、更多样化的患者及医生群体进行深入研究，以验证该工具的可推广性，并评估营养干预对患者结局的影响。
肿瘤(癌症)患者之家